Stability of L-asparaginase: An enzyme used in leukemia treatment

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 1, 1999, Pages 1-9

  Stecher, A L ^a   Morgantetti De Deus, P ^a   Polikarpov, I ^b   Abrahao Neto J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

Author keywords

L asparaginase; Leukemia; Stabilization; Storage

Indexed keywords

ASPARAGINASE; BACTERIAL ENZYME; BUFFER; DILUENT; PARENTERAL SOLUTION; SODIUM ION;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME STABILITY; ENZYME STRUCTURE; ESCHERICHIA COLI; FREEZE DRYING; LEUKEMIA; PH; RECIPIENT; STORAGE; TEMPERATURE;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; ENZYME STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKEMIA;

EID: 0033392394     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00009-6     Document Type: Article

References (31)

1. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
2. Broome J.D. L-asparaginase: discovery and development as a tumor-inhibitory agent. Cancer Treat. Rep. 65:1981;111-114.
3. Cammack K.A., Marlborough D.I., Miller D.S. Physical properties and subunit structure of L-asparaginase isolated from Erwinia carotovora. Biochem. J. 126:1972;361-379.
4. Capizzi R.L., Poole M., Cooper M.R., Richards F., Stuart J.J., Jackson D.V., White D.R., Spurr C.L., Hopkins J.O., Muss H.B. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood. 63:1984;694-700.
5. Cunningham I., Gee T., Dowling M., Chaganti R., Bailey R., Hopfan S., Bowden L., Turnbull A., Knapper W., Clarkson B. Results of treatment of Ph′+chronic myelogenous leukemia with an intensive teatment regimen (l-5 protocol). Blood. 53:1979;375-395.
6. Derst C., Hensenling J., Rohm K.H. Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis. Protein Eng. 5:1992;785-789.
7. Derst, C., Wehner, A., Specht, V., Rohm, K.H., 1994. States and functions of tyrosine residues in Escherichia coli asparaginase II. Eur. J. Biochem. 224, 553-540.
8. Drainas D., Drainas C. A conductimetric method for assaying asparaginase activity in Aspergillus nidulans. Eur. J. Biochem. 151:1985;591-593.
9. Harms E., Wehner A., Aung H.P., Rohm K.H. A catalytic role for threonine-12 of E. coli asparaginase II as established by site-directed mutagenesis. FEBS Lett. 285:1991;55-58.
10. Klumper E., Pieters R., Veerman A.J., Huismans D.R., Loonen A.H., Hahlen K., Kaspers G.J., Van Wering E.R., Hartmann R., Henze G. In vitro cellular drug resistence in children with relapsed/refractory acute lymphoblastic leukemia. Blood. 86:1995;3861-3868.
11. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24:1991;946-950.
12. Laemmli U.K. Cleavage of strutural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
13. Larson R.A., Dodge R.K., Burns C.P., Lee E.J., Stone R.M., Schulman P., Duggan D., Davey F.R., Sobol R.E., Frankel S.R. A five-drug remission induction regimen with intensive consolidation for adults with limphoblastic leukemia: cancer and leukemia group B study 8811. Blood. 85:1995;2025-2037.
14. Law A.S., Wriston J.C. Purification and properties of Bacillus coagulans L-asparaginase. Arch. Biochem. Biophys. 147:1971;744-752.
15. Levine A.M., Forman S.J., Meyer P.R., Koehler S.C., Liebman H., Paganini-Hill A., Pockros A., Lukes R.J., Feinstein D.I. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood. 61:1983;92-98.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Lubkowski J., Wlodawer A., Ammon H.L., Copeland T.D., Swain A.L. Structural characterization of Pseudomonas 7A glutaminase-asparaginase. Biochemistry. 33:1994;10257-10265.
18. Lubkowski J., Palm G.J., Giliand G.L., Derst C.K., Rohm H., Wlodawer A. Crystal structure and amino acid sequence of Wolinella succinogenes L-asparaginase. Eur. J. Biochem. 241:1996;201-207.
19. Marlborough D.I., Miller D.S., Cammack K.A. Comparative study on conformational stability and subunit interactions of two bacterial asparaginases. Biochim. Biophys. Acta. 386:1975;576-589.
20. Miller M., Mohana Rao J.K., Wlodawer A., Gribskov M.R. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate. FEBS Lett. 328(3):1993;275-279.
21. Mitchell L., Hoogendoorn H., Giles A.R., Vegh P., Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency. Blood. 83:1994;386-391.
22. Moola Z.B., Scawen M.D., Atkinson T., Nicholls D.J. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes. Biochem. J. 302:1994;921-927.
23. Palm G.J., Lubkowski J., Derst C., Schleper S., Rohm K.-H., Wlodawer A. A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant. FEBS Lett. 390:1996;211-216.
24. Ravindranath Y., Abella E., Krischer J.P., Wiley J., Inoue S., Harris M., Chauvenet A., Alvarado C.S., Dubowy R., Ritchey A.K., Land V., Stueber C.P., Weinstein H. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood. 80:1992;2210-2214.
25. Ryoyama C. Nature of protective action of sodium and potassium ions against heat inactivation of Escherichia coli L-asparaginase. Biochim. Biophys. Acta. 26:1972;539-541.
26. Shifrin S., Solis B.G., Chaiken I.M. L-asparaginase from Erwinia carotovora. Physicochemical properties of the native and succinylated enzyme. J. Biol. Chem. 248:1973;3464-3469.
27. Swain A.L., Jaskolski M., Housset D., Mohana Rao J.K., Wlodawer A. Crystal struture of E. coli asparaginase, an enzyme used in cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1474-1478.
28. Wade H.E., Phillips B.P. Automated determination of bacterial asparaginase and glutaminase. Anal. Biochem. 44:1971;189-199.
29. Wehner A., Harms E., Jennings M.P., Beacham I.R., Derst C., Bast P., Rohm K.H. Site-specific mutagenesis of Escherichia coli asparaginase: II. None of the three histidine residues is required for catalysis. Eur. J. Biochem. 208:1992;475-480.
30. Whelan H.A., Wriston J.C. Purification and properties of asparaginase from Escherichia coli B. Biochemistry. 8:1969;2386-2393.
31. Wriston J.C. Asparaginase. Methods Enzymol. 113:1985;608-618.